P

PTC Therapeutics

Biopharmaceuticals for rare genetic disorders

Associate Director, Pharmacovigilance

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listed

About the Job

Requirements

  • A Bachelor of Science in Nursing, a Bachelor's degree in Pharmacy, or a related life science discipline, and at least 8 years of progressively responsible pharmacovigilance experience in a pharmaceutical, biotechnology, or related environment.
  • Demonstrated expert knowledge of relevant Food and Drug Administration, European Union, and International Council for Harmonisation guidelines, initiatives, and regulations governing pharmacovigilance.
  • Experience in scientific writing, project management, and leading and contributing to required safety reports.
  • Extensive working knowledge of medical terminology and the Medical Dictionary for Regulatory Activities.
  • Hands-on experience identifying, developing, and implementing departmental process improvements that increase efficiency and maintain or improve quality.
  • Proficiency with Microsoft Office.
  • Ability to work independently and collaboratively in a fast-paced matrixed team environment with internal and external team members.
  • Ability to influence without direct authority.

Responsibilities

  • Responsible for assigned products or therapeutic-area pharmacovigilance activities.
  • Manage the compilation of pharmacovigilance aggregate reports, including Development Safety Update Reports, Periodic Benefit Risk Evaluation Reports, and topic reports.
  • Collaborate with the safety physician to plan for stakeholder input on applicable sections of pharmacovigilance reports and meet regulatory reporting deadlines.
  • Contribute to relevant sections of pharmacovigilance safety reports in collaboration with the safety physician.
  • Provide training and guidance to other functions on ad hoc questions and issues related to pharmacovigilance safety reports.
  • Lead the review process for pharmacovigilance aggregate reports and oversee their finalization with internal and external stakeholders.
  • Collaborate with clinical teams, contract research organizations, Regulatory Affairs, and other stakeholders to ensure aggregate reports are submitted to regulatory authorities on time and track submissions.
  • Manage compilation of safety information for Clinical Overviews, regulatory-question responses, post-marketing safety assessments, Risk Management Plans, labeling justifications, Company Core Safety Information development, Investigator Brochure updates, label updates, and written summaries.
  • Provide and oversee technical and scientific support for safety surveillance and signal detection activities for company products.
  • Plan and ensure routine and ad hoc cross-functional Safety Review Board meetings alongside the safety physician.
  • Contribute to Risk Management Plan updates and track and present regulatory and Risk Management Plan commitments during Safety Review Board processes; liaise with Safety Review Board chairs to support communication and decisions, including updates to Risk Management Plans, labeling, regulatory notifications, and other required actions.
  • Represent Pharmacovigilance in cross-functional clinical program teams and support development programs and registration activities.
  • Support the Drug Safety Monitoring Board and clinical trials, and contribute to investigator meetings as needed.
  • Interface with medical monitors on medical assessment and regulatory classification of serious adverse events, and facilitate serious adverse event reconciliation across projects.
  • Assist with serious adverse event follow-up and case closure as needed.
  • Perform other tasks and assignments as specified by management.
  • Collaborate with European Union and local Qualified Persons to develop or maintain pharmacovigilance processes for development and marketed products.

Desired Qualifications

  • Experience in gene therapy is a strong advantage.
  • Expertise in electronic document management system software.

About the Company

PTC Therapeutics

Biopharmaceuticals for rare genetic disorders

PTC Therapeutics develops and commercializes treatments for rare genetic disorders worldwide, leveraging RNA biology and post-transcriptional control. Its portfolio includes Translarna (ataluren) for nonsense-mutant Duchenne muscular dystrophy, Evrysdi (risdiplam) for spinal muscular atrophy, Emflaza (deflazacort) for DMD, and Upstaza for AADC deficiency, among others. The company uses an integrated model spanning discovery, clinical development, manufacturing, and global commercialization, with operations in 50+ countries and a European base in Dublin. Its goal is to provide safe, effective therapies for patients with limited treatment options and to grow a robust pipeline in rare diseases.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Warren Township, New Jersey
Founded
1998

Recently Posted Jobs

Explore more opportunities at PTC Therapeutics

See more jobs